Monthly Archives: October 2011

Discovery Of Gatekeepers In The Human Cell ‘Shredder’ Could Lead To A New Target For Cancer Drugs

Insulin, a hormone released in large quantities when food is consumed, is reduced by 50% only three to five minutes later. However, if the cell’s internal waste disposal system malfunctions, illnesses such as Alzheimer’s or Parkinson’s disease may occur. To … Continue reading

Posted in Uncategorized

Shape Matters In The Case Of Cobalt Nanoparticles

Shape is turning out to be a particularly important feature of some commercially important nanoparticles – but in subtle ways. New studies* by scientists at the National Institute for Standards and Technology (NIST) show that changing the shape of cobalt … Continue reading

Posted in Uncategorized

Glivec Helps 90% Of Myeloid Leukaemia Patients Live 5 Years Or More

Clinical trial results show that Glivec helps 90% of patients with myeloid leukaemia survive for five years or more. In the UK the National Institute of Clinical Excellence (NICE) only wanted to approve its use for patients with advanced myeloid … Continue reading

Posted in Uncategorized

NIH Director Announces 2007 Pioneer Award Competition

NIH Director Elias A. Zerhouni, M.D., has launched a new round of competition for the NIH Director’s Pioneer Award. This signature program supports exceptionally creative scientists who take highly innovative – and potentially transformative – approaches to major challenges in … Continue reading

Posted in Uncategorized

Inherited Mitochondrial Disease Could Be Eliminated By New Technique

Researchers funded by the National Institutes of Health have developed an experimental technique with the potential to prevent a class of hereditary disorders passed on from mother to child. The technique, as yet conducted only in nonhuman primates, involves transferring … Continue reading

Posted in Uncategorized

First Structure Of A Class Of Proteins That Help Guide Blood Cell Movement Revealed: Findings May Lead To New Drugs For Cancer, Immune Disorders Aids

Researchers have determined the structure of a protein that helps guide blood-forming stem cells, or hematopoetic stem cells. The protein is also one of the main receptors used by the human immunodeficiency virus (HIV) to get inside blood cells. The … Continue reading

Posted in Uncategorized

Breast Cancer Confessions: The Emotional Work Of Disclosing A Diagnosis

Women diagnosed with breast cancer shoulder the emotional burden of disclosing their diagnosis to loved ones, managing the feelings of others at precisely the time when they need support themselves, according to research to be presented at the annual meeting … Continue reading

Posted in Uncategorized

European CHMP Issues Positive Opinion For ATRIPLA(R) (Efavirenz 600mg/Emtricitabine 200 Mg/Tenofovir Disoproxil Fumarate 300 Mg)

Bristol-Myers Squibb Company (NYSE:BMY), Gilead Sciences, Inc. (Nasdaq:GILD) and Merck & Co., Inc. (NYSE:MRK) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion on the Marketing Authorisation … Continue reading

Posted in Uncategorized

MMWR Looks At Increase In HIV Cases, Risk Factors Among Black MSM In Jackson, Miss.

A survey of 29 black men who have sex with men in Jackson, Miss., identified some common behaviors that place them at a risk of contracting HIV, according to a study published Friday in CDC’s Morbidity and Mortality Weekly Report, … Continue reading

Posted in Uncategorized

Debate Over Thai Compulsory Licensing Will Undermine Drug Industry’s Ability To Provide Medicines To Developing Countries, Editorial Says

Although pharmaceutical company Abbott Laboratories offers many of the world’s poorest countries with a discounted price for its antiretroviral drug Kaletra, it continues to be “attacked as a price-gouging capitalist indifferent to the suffering of the poor,” a Chicago Tribune … Continue reading

Posted in Uncategorized